Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

VE 202

Drug Profile

VE 202

Alternative Names: JNJ 67670187; VE-202

Latest Information Update: 30 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Vedanta Biosciences
  • Developer Janssen; Vedanta Biosciences
  • Class Anti-inflammatories; Bacteria
  • Mechanism of Action Bacteria replacements; Gastrointestinal microbiome modulators; Regulatory T-lymphocyte modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Inflammatory bowel diseases; Ulcerative colitis
  • No development reported Autoimmune disorders

Most Recent Events

  • 28 Nov 2023 Vedanta Biosciences has patent protection for cover compositions of clostridia bacterial species in European Union
  • 04 Oct 2023 VE 202 receives Fast Track designation for Ulcerative colitis [PO,Capsule] (In the elderly, In adults) in USA
  • 08 May 2023 Phase-II clinical trials in Inflammatory bowel diseases (In volunteers) in Netherlands, USA, Belgium (PO)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top